CNL8 - 68712-027-01 - (Ciclopirox)

Alphabetical Index


Drug Information of CNL8

Product NDC: 68712-027
Proprietary Name: CNL8
Non Proprietary Name: Ciclopirox
Active Ingredient(s): 2.28    g/mL & nbsp;   Ciclopirox
Administration Route(s): TOPICAL
Dosage Form(s): SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of CNL8

Product NDC: 68712-027
Labeler Name: Innocutis Holdings LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA078270
Marketing Category: ANDA
Start Marketing Date: 20081031

Package Information of CNL8

Package NDC: 68712-027-01
Package Description: 3 BOTTLE, GLASS in 1 CARTON (68712-027-01) > 5 mL in 1 BOTTLE, GLASS (68712-027-03)

NDC Information of CNL8

NDC Code 68712-027-01
Proprietary Name CNL8
Package Description 3 BOTTLE, GLASS in 1 CARTON (68712-027-01) > 5 mL in 1 BOTTLE, GLASS (68712-027-03)
Product NDC 68712-027
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Ciclopirox
Dosage Form Name SOLUTION
Route Name TOPICAL
Start Marketing Date 20081031
Marketing Category Name ANDA
Labeler Name Innocutis Holdings LLC
Substance Name CICLOPIROX
Strength Number 2.28
Strength Unit g/mL
Pharmaceutical Classes Decreased DNA Replication [PE],Decreased Protein Synthesis [PE],Decreased RNA Replication [PE],Protein Synthesis Inhibitors [MoA]

Complete Information of CNL8


General Information